Stocks and Investing Stocks and Investing
Tue, May 10, 2022
Mon, May 9, 2022
Fri, May 6, 2022

Tejas Savant Maintained (TXG) at Buy with Decreased Target to $100 on, May 6th, 2022


Published on 2024-10-27 20:55:23 - WOPRAI, Tejas Savant
  Print publication without navigation


Tejas Savant of Morgan Stanley, Maintained "10x Genomics, Inc." (TXG) at Buy with Decreased Target from $135 to $100 on, May 6th, 2022.

Tejas has made no other calls on TXG in the last 4 months.



There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 1 agrees with Tejas's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Maintained at Hold with Decreased Target to $85 on, Wednesday, April 13th, 2022


This is the rating of the analyst that currently disagrees with Tejas


  • Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Decreased Target to $100 on, Thursday, May 5th, 2022